Broadcom
AVGO
Alibaba
BABA
NVIDIA
NVDA
Tesla
TSLA
Advanced Micro Devices
AMD
US Stock MarketDetailed Quotes
GSK GlaxoSmithKline
- 33.430
- -0.010-0.03%
Close Jan 17 16:00 ET
- 33.430
- 0.0000.00%
Post 20:01 ET
68.21BMarket Cap22.63P/E (TTM)
33.605High33.250Low3.93MVolume33.600Open33.440Pre Close131.29MTurnover0.20%Turnover Ratio11.46P/E (Static)2.04BShares44.86352wk High4.00P/B66.07BFloat Cap31.71552wk Low1.61Dividend TTM1.98BShs Float44.863Historical High4.81%Div YieldTTM1.06%Amplitude6.376Historical Low33.402Avg Price1Lot Size
GlaxoSmithKline News
6-K: Report of foreign private issuer [Rules 13a-16 and 15d-16]
6-K: Transaction Notification
6-K: Transaction Notification
6-K: Transaction Notification
6-K: Gsk Enters Agreement to Acquire Idrx, Inc.
6-K: Gsk's Shingrix New Prefilled Syringe Presentation Accepted for Review by Us Fda
6-K: Gsk's B7-H3-Targeted Antibody-Drug Conjugate, Gsk'227, Receives Us Fda Breakthrough Therapy Designation in Late-Line Relapsed or Refractory Osteosarcoma
6-K: Gsk's Nucala (Mepolizumab) Approved in China for Treatment of Adults with Chronic Rhinosinusitis with Nasal Polyps
6-K: Total Voting Rights and Capital
6-K: Transaction Notification
6-K: Block Listing Application
6-K: Gsk Announces First Trial Met Its Primary Endpoint of Progression Free Survival in First Line Advanced Ovarian Cancer
6-K: Jemperli (Dostarlimab) Receives Us Fda Breakthrough Therapy Designation for Locally Advanced Dmmr/Msi-H Rectal Cancer
6-K: Gsk's B7-H3-Targeted Antibody-Drug Conjugate, Gsk'227, Receives Ema Priority Medicines (Prime) Designation in Relapsed Extensive-Stage Small-Cell Lung Cancer
6-K: Jemperli (Dostarlimab) Plus Chemotherapy Receives Positive Chmp Opinion to Expand Approval to All Adult Patients with Primary Advanced or Recurrent Endometrial Cancer
6-K: Transaction Notification
6-K: Blenrep Shows Significant Overall Survival Benefit, Reducing the Risk of Death by 42% in Multiple Myeloma at or After First Relapse
6-K: Blenrep Combination Accepted for Priority Review in China in Relapsed/Refractory Multiple Myeloma
6-K: Us Fda Accepts Gsk's Submission for the Use of Nucala (Mepolizumab) in Copd
6-K: Gsk and Zhifei Revise and Extend Strategic Vaccine Collaboration in China
Trending US Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
